Dividend compounder review

VRTX

Vertex Pharmaceuticals Inc · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score56.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 25.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 6.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 8.5 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$4.0B
Free Cash Flow$3.2B
FCF Covers DividendUnknown
Debt / Equity0.10
P/E26.4
Revenue Growth 5Y14.2%
Net Margin35.5%
ROE24.2%
Price vs Trend-1.5%
3Y Return28.2%
5Y Return128.9%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

VRTX dividend review warning Warning · Warning

No usable dividend history found.